The US Now Has a Research Plan for Long COVID—Is It Enough?; Debate Swirls Around the Relevance of the Amyloid Hypothesis in Alzheimer Disease Research; Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive Related Content: The US Now Has a Research Plan for Long COVID—Is It Enough? Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches Microplastics Are Found Outside in Nature and Inside the Body—but Evidence of Health Risks Is Inconclusive Animal Reservoirs—Where the Next SARS-CoV-2 Variant Could Arise Large Autopsy Study Estimates Prevalence of “LATE” Neuropathologic Change Addressing the Long-term Effects of COVID-19 Long COVID: The US Federal Response (audio) Long COVID: The US Federal Response (video)